Side Effects – Page 222

Zymfentra (Infliximab-dyyb): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Zymfentra Zymfentra is a highly advanced biological therapy representing the first FDA-approved subcutaneous formulation of infliximab-dyyb designed specifically for the continuous maintenance treatment of severe inflammatory bowel disease. The most notable side effect is profound systemic immunosuppression leading to a drastically heightened susceptibility to serious opportunistic infections. Infliximab-dyyb … Read more

Avtozma (Tocilizumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Avtozma Avtozma incorporates tocilizumab as a highly potent recombinant humanized monoclonal antibody designed to aggressively suppress severe systemic autoimmune inflammation by neutralizing the interleukin-6 receptor. The most notable side effect involves a profoundly heightened susceptibility to serious opportunistic infections and highly dangerous hepatotoxicity. Tocilizumab functions as an explicit … Read more

Osenvelt (Denosumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Osenvelt Osenvelt is a highly concentrated formulation of denosumab utilized primarily in oncology to prevent severe skeletal-related events in patients with bone metastases from solid tumors and to treat giant cell tumor of bone. The most notable side effect involves a profoundly dangerous drop in systemic calcium levels … Read more

Stoboclo (Denosumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Stoboclo Stoboclo is a potent bone-modifying agent utilizing denosumab as a fully human monoclonal antibody designed to aggressively treat osteoporosis and prevent skeletal-related events in patients with bone metastases. The most notable side effect involves profound systemic hypocalcemia and the rare but severe risk of osteonecrosis of the … Read more

Omlyclo (Omalizumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Omlyclo Omlyclo utilizes omalizumab as a targeted recombinant DNA-derived humanized monoclonal antibody to treat moderate to severe persistent asthma and chronic spontaneous urticaria. The most notable side effect involves a highly elevated risk of anaphylaxis which can occur immediately or days after administration. Omalizumab functions by specifically binding … Read more

Steqeyma (Ustekinumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Steqeyma Steqeyma is a highly advanced biological therapy utilizing ustekinumab, a fully human monoclonal antibody designed to aggressively treat severe plaque psoriasis, psoriatic arthritis, and severe inflammatory bowel diseases. The most notable side effect involves a profoundly elevated risk of severe systemic opportunistic infections due to its highly … Read more

Zymfentra (Infliximab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Zymfentra Zymfentra is a highly advanced biological therapy representing the first FDA-approved subcutaneous formulation of infliximab, designed specifically for the continuous maintenance treatment of severe inflammatory bowel disease. The most notable side effect is profound, systemic immunosuppression, leading to a drastically heightened susceptibility to serious opportunistic infections. Infliximab … Read more

Yuflyma (Adalimumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Yuflyma Yuflyma is a highly concentrated, citrate-free biosimilar to reference adalimumab, functioning as a profound biological disease-modifying antirheumatic drug (bDMARD). The most notable side effect involves a profoundly elevated risk of catastrophic opportunistic infections due to its aggressive suppression of the human immune system. Yuflyma is a recombinant … Read more

Adalimumab: Usage Guidelines, Side Effects & Dosage

1. Introduction & Mechanism of Action of Adalimumab Adalimumab is a potent biological disease-modifying antirheumatic drug (bDMARD) designed to aggressively suppress autoimmune inflammation by neutralizing tumor necrosis factor-alpha (TNF-alpha). The most notable side effect involves a profoundly heightened susceptibility to serious systemic infections, including the reactivation of latent tuberculosis. Adalimumab is a recombinant human IgG1 … Read more

Vegzelma (Bevacizumab): Uses, Side Effects & Interactions

1. Introduction & Mechanism of Action of Vegzelma Vegzelma is a targeted biological therapy containing bevacizumab, a recombinant humanized monoclonal antibody utilized extensively in oncology to starve malignant tumors of their blood supply. The most notable side effect involves a profound risk of severe hemorrhagic events and acute hypertension. Bevacizumab acts as a direct angiogenesis … Read more